ClinicalTrialsFinder

Phase 1 Digestive System Neoplasm Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting
Phase 1

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms

Digestive System Neoplasms
Sir Run Run Shaw Hospital20 enrolled1 locationNCT06026800
Recruiting
Phase 1

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System Neoplasms

Digestive System Neoplasms
Sir Run Run Shaw Hospital20 enrolled1 locationNCT06019702
Recruiting
Phase 1

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms

Digestive System Neoplasms
Sir Run Run Shaw Hospital20 enrolled1 locationNCT06026774